Author

Robyn A. Wong

City Of Hope National Medical Center

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Biology Disciplines

Click to filter author papers

Cancer Biology· 2

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:differential expression· 2 Research Focus:drug response / drug discovery· 2 Approach:experimental assay· 2 Organism:human· 2 Organism:mouse· 2 Assay:scRNA-seq· 2 Approach:statistical model· 2 Research Focus:cell type annotation· 1

Frequent Co-Authors

Behnam BadieiD· 2 shared Christine E. BrowniD· 2 shared Heini M. NatriiD· 2 shared Nicholas E. BanovichiD· 2 shared Renate StarriD· 2 shared Stephen J. FormaniD· 2 shared Xiwei WuiD· 2 shared Antoni RibasiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

2 shared papersCancer Biology

Behnam BadieORCID

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Therapeutic Targeting of the TGFβ Pathway Augments CAR T cell Efficacy in Glioblastoma

Darya Alizadeh, Robyn A. Wong, Madeleine S. Maker, Dominic J. Bellavari, Jonathan C. Hibbard, Heini M. Natri, Wuyang Chen, Min-Hsuan Chen, Xiwei Wu, Yate‐Ching Yuan, Joseph R. Pecoraro, John David Jeppson, Renate Starr, Zhiqiang Wang, Nicholas E. Banovich, , Christine E. Brown

This study shows that targeting the TGFβ pathway improves CAR T cell efficacy in glioblastoma by enhancing antitumor activity and modulating the tumor microenvironment.

bioRxiv · Oct 28, 2026 · PreprintCancer Biology

Overcoming myeloid-driven resistance to CAR T therapy by targeting SPP1

Sharareh Gholamin, Heini M. Natri, Yuqi Zhao, Shengchao Xu, Maryam Aftabizadeh, Begonya Comin-Anduix, Supraja Saravanakumar, Christian Masia, Robyn A. Wong, Lance M. Peter, Mei-I Chung, Evan D. Mee, Brenda Aguilar, Renate Starr, Davis Yuri Torrejon, , Christine E. Brown

This study identifies SPP1+ macrophages as key drivers of resistance to CAR T therapy in solid tumors and shows that targeting SPP1 can overcome this resistance.

bioRxiv · Apr 1, 2025 · PreprintCancer Biology